Funding to create new research projects for muscular dystrophy Published on: 29 August 2024 Muscular Dystrophy UK is funding 12 new research projects worth 拢1.7 million across England and Scotland, with three of them based at 缅北禁地. The three new research projects worth £390,000 that will be created at 缅北禁地 seek to improve diagnosis, progression, and potential new treatments of muscular dystrophy (MD). The research will allow 缅北禁地 to assist in developing a gene therapy for desminopathy (a form of myofibrillar myopathy that causes weakness and affects muscle function) and to explore the molecular processes that cause the progression of facioscapulohumeral muscular dystrophy (FSHD), which most typically affects the muscles of the face, shoulder blades, and upper arms. Professor Giorgio Tasca. 'Funding will make a significant difference' Giorgio Tasca, Clinical Professor of Neuromuscular Science at 缅北禁地, confirmed that the funding will help experts better understand the molecular processes that cause the progression of FSHD. He said: “This funding will make a significant difference in people’s lives by finally leading to improved treatment options. It may provide people with new indicators to monitor condition progression and more effective and targeted therapies, reducing symptoms and offering hope for better outcomes.” Jordi Diaz-Manera, Professor of Neuromuscular Diseases, Translational Medicine and Genetics at 缅北禁地, will look to advance the diagnosis of people with muscle-wasting conditions via the use of MRI scans and artificial intelligence. Professor Diaz-Manera said: “The aim of the research project is to help clinicians around the world to provide diagnosis of patients with neuromuscular conditions quickly, looking at technology like AI, to do so. After more than 20 years of seeing patients with neuromuscular conditions, I’ve realised how important it is to reach a diagnosis early. “Ultimately, this research project will help to establish a tailored care plan and open the door to research and potential medications. This helps to do genetic counselling and allows the team to establish clear expectations for the future.” 'We fund the highest quality research' The third grant will be funding Dr Michael Keogh, Senior Clinical Fellow and Honorary Consultant Neurologist at 缅北禁地. His 12-month project, co-funded by the charity and AFM Telethon (France), will look to develop a gene therapy for desminopathy. The new grants will bring the total number of research projects funded by Muscular Dystrophy UK to 51, as they aim to bring research forward in order to improve the lives of those living with muscle-wasting conditions. Dr Kate Adcock, Director of Research and Innovation at Muscular Dystrophy UK, said: “Every year at Muscular Dystrophy UK, we look to fund the highest quality research including the three projects at 缅北禁地.” Read more about , and . Discover more about Muscular Dystrophy UK’s research projects . Latest News Comment: An expert explains what happened in Nepal Writing for The Conversation, Professor Stuart Dunning discusses how a collapsing glacier turned into a lethal wall of mud and water. published on: 28 August 2026 Comment: Britain鈥檚 quarter century Writing for The Conversation, Professor Hayley Fowler discusses how the UK environment has changed in the past 25 years. published on: 27 August 2026 缅北禁地 academic receives esteemed mid-career Fellowship A 缅北禁地 researcher has been awarded an esteemed Fellowship by the Independent Social Research Foundation (ISRF). published on: 21 August 2026 Facts and figures
![缅北禁地 logo](/gomobileassets/img/logo.svg" "缅北禁地"){kind=logo}